ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 581,25
-0,67%
Dow Jones
40 211,72
0,53%
DAX
18 500,78
-0,53%
Brent Oil
83,77
-0,68%
Bitcoin
63 130,30
-2,65%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
07/04/202013h30PR Newswire (Canada)L'engagement de Teva Canada envers les proches aidants canadiensNYSE:TEVATeva Pharmaceutical Industries Ltd
07/04/202013h30PR Newswire (Canada)Teva Canada Committed to Canadian CaregiversNYSE:TEVATeva Pharmaceutical Industries Ltd
20/03/202001h23Business WireTeva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals NationwideNYSE:TEVATeva Pharmaceutical Industries Ltd
16/03/202013h00Business WireTeva and Celltrion Healthcare Announce U.S. Availability of HERZUMA® (trastuzumab-pkrb) for InjectionNYSE:TEVATeva Pharmaceutical Industries Ltd
12/03/202017h14Business WireAvis favorable de l'Institut national pour l'excellence clinique (NICE) pour le premier traitement anti-PRGC de la migraine :...NYSE:TEVATeva Pharmaceutical Industries Ltd
12/03/202017h03Business WirePositive Empfehlung des NICE für die erste, gegen das CGRP gerichtete Migränetherapie: AJOVY®▼ (Fremanezumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
12/03/202008h30Business WirePositive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®▼ (fremanezumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
24/02/202015h13Dow Jones NewsTeva Gets FDA Approval for ArmonAir Digihaler Inhalation PowderNYSE:TEVATeva Pharmaceutical Industries Ltd
24/02/202014h00Business WireTeva Announces FDA Approval of ArmonAir® Digihaler™ (fluticasone propionate) Inhalation PowderNYSE:TEVATeva Pharmaceutical Industries Ltd
19/02/202022h05Business WireTeva Announces Registration Trials of Deutetrabenazine in Pediatric Patients with Tourette Syndrome Did Not Meet the Primary ...NYSE:TEVATeva Pharmaceutical Industries Ltd
12/02/202013h30Business WireNew Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 BillionNYSE:TEVATeva Pharmaceutical Industries Ltd
12/02/202013h00Business WireTeva Reports Fourth Quarter and Full Year 2019 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
06/02/202007h14Business Wireテバが日本でのAJOVY®（フレマネズマブ）の臨床試験の良好なトップライン結果を発表NYSE:TEVATeva Pharmaceutical Industries Ltd
03/02/202009h30Business WireTeva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in JapanNYSE:TEVATeva Pharmaceutical Industries Ltd
28/01/202023h16Dow Jones NewsTeva Says FDA Approves Ajovy AutoinjectorNYSE:TEVATeva Pharmaceutical Industries Ltd
28/01/202022h05Business WireTeva Announces FDA Approval of AJOVY® (fremanezumab-vfrm) Injection AutoinjectorNYSE:TEVATeva Pharmaceutical Industries Ltd
15/01/202023h00Business WireTeva to Host Conference Call to Discuss Fourth Quarter 2019 Financial Results & 2020 Financial Guidance at 8 a.m. ET on Febru...NYSE:TEVATeva Pharmaceutical Industries Ltd
10/01/202020h18Dow Jones NewsEndo Agrees to Pay $8.8 Million to Settle Oklahoma Opioid CaseNYSE:TEVATeva Pharmaceutical Industries Ltd
06/01/202023h22Business WireTeva to Present at the 38th Annual J.P. Morgan Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
02/01/202022h26Dow Jones NewsDrug Prices Climb by 5.8% on Average, Less Than Last YearNYSE:TEVATeva Pharmaceutical Industries Ltd
16/12/201913h30GlobeNewswire Inc.NexImmune Appoints Sol Barer as Chairman of the Board of DirectorsNYSE:TEVATeva Pharmaceutical Industries Ltd
27/11/201909h02Dow Jones NewsOpioid Makers Hit With Criminal Probe -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
26/11/201919h51Dow Jones NewsOpioid Makers, Distributors Fall Following WSJ Report on Federal ProbeNYSE:TEVATeva Pharmaceutical Industries Ltd
26/11/201919h18Dow Jones NewsFederal Prosecutors Launch Criminal Probe of Opioid Makers, DistributorsNYSE:TEVATeva Pharmaceutical Industries Ltd
25/11/201914h00Business WireTeva Announces Early Tender Results of its Debt Tender Offer and Election of Early SettlementNYSE:TEVATeva Pharmaceutical Industries Ltd
19/11/201919h21Business WireTeva Announces Successful Upsize of Senior Notes Offering and Pricing of $2.1 Billion of Senior NotesNYSE:TEVATeva Pharmaceutical Industries Ltd
16/11/201909h02Dow Jones NewsJohnson & Johnson Opioid Verdict Cut -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201923h15Dow Jones NewsJohnson & Johnson's Oklahoma Opioid Penalty Reduced to $465 MillionNYSE:TEVATeva Pharmaceutical Industries Ltd
08/11/201915h44Business WireTeva Announces $1.5 Billion Debt Tender OffersNYSE:TEVATeva Pharmaceutical Industries Ltd
08/11/201915h43Business WireTeva Announces Launch of $1,500,000,000 Offering of Senior NotesNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

COIN
BTGMGBP
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés